Modalities

With extensive experience across emerging and complex modalities, BioAgilytix provides tailored bioanalytical strategies to meet your program’s needs

Speak to a Scientist
Home Solutions Modalities

Bioanalysis and CMC analytical services for every modality

Complex therapeutics require scientifically aligned analytical strategies capable of supporting modality-specific challenges, regulatory expectations, and global demands. BioAgilytix offers industry-leading services and solutions designed to support even the most complex modalities.

Expert large molecule bioanalysis testing services for every phase

Bioanalytical support for large molecule therapeutics requires a CRO provider with a comprehensive depth of expertise across therapeutic modalities and a large selection of bioanalytical tools or resources. BioAgilytix provides industry-leading expertise across a wide range of large molecule modalities, including:

Industry-leading small molecule bioanalysis for drug development

We provide discovery bioanalysis (non-GLP), regulated bioanalysis, and high-throughput bioanalysis for small molecules to support the following therapeutic development studies: develop, validate, and perform laboratory developed tests (LDTs) and FDA-cleared assays.

Comprehensive support for vaccine development programs

Specialized bioanalytical support across vaccine generations — from infectious agent-based vaccines to the latest nucleic acid and vector-based platforms. We combine deep scientific expertise with regulatory know-how to deliver the critical data you need to characterize immune responses, assess potency, and ensure safety throughout your vaccine’s lifecycle.

Don’t let unexpected challenges delay your program

Work with a team of industry experts who have extensive knowledge of modality-specific challenges and understand the importance of a bioanalytical program tailored to your program’s needs

speak to a scientist